NL0015002CX3
NL0015002CX3
QIAGEN
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 8.28B EUR | 6.98B EUR | 7.14B EUR | 8.43B EUR |
Enterprise Value | 9.14B EUR | 7.85B EUR | 8.14B EUR | 9.4B EUR |
Valuation Multiples | ||||
Trailing P/E | 23.72x | 17.05x | 17.77x | 25.23x |
Forward P/E | -- | -- | -- | -- |
Price to Sales | 3.94x | 3.32x | 3.4x | 5.25x |
Price to Book | 2.76x | 2.08x | 2.14x | 2.23x |
EV/Revenue | 4.35x | 3.74x | 3.88x | 5.85x |
EV/EBITDA | 12.45x | 10.13x | 10.52x | 15.84x |
Price to FCF (P/FCF) | 22.21x | 15.84x | 17.69x | 23.97x |
EV/FCF | 24.51x | 17.82x | 20.17x | 26.74x |
FCF Yield | 4.5% | 6.31% | 5.65% | 4.17% |